Clinical Trials Sponsored by BioSight Ltd.

Total 16899 results

BioSight Ltd.

Active, not recruiting

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Refractory Acute Myeloid Leukemia | MDS | AML, Adult | Relapse/Recurrence

United States
BioSight Ltd.

Completed

Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (BSTPHASE1-01)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

Israel
BioSight Ltd.

Recruiting

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

AML, Adult

United States
BioSight Ltd.

Completed

Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy (ELPIS)

Acute Myeloid Leukemia

United States, Israel
Insight Lifetech Co., Ltd.

Completed

A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter

Chronic Total Occlusion (CTO) | Coronary Artery Disease Obliterative

Singapore, Georgia, Greece
Biolight AB

Unknown

Monochromatic Phototherapy on Diabetic Foot Ulcers

Diabetic Foot Ulcers

Sweden
Beijing Insight Science & Technology Co. Ltd.

Unknown

Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

Primary Liver Cancer
Beijing Insight Science & Technology Co. Ltd.

Unknown

Chinese Liver Cancer Clinical Survey (CLCS)

Primary Liver Cancer
CoreAalst BV
Insight Lifetech Co., Ltd.

Recruiting

INSIGHTFUL-FFR Clinical Trial

Coronary Artery Disease | Acute Coronary Syndrome

Spain, Belgium, China, Germany, Poland
Research Insight LLC

Completed

The Chronology of Lifitegrast Effect on Anterior Surface Rehabilitation (CLEAR) Study (CLEAR)

Dry Eye

United States
Research Insight LLC

Completed

Veracity Surgical: A Time/Motion and Quality of Care Study

Cataract

United States
Research Insight LLC

Completed

The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance

Cataract Surgery

United States
Research Insight LLC

Completed

The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction

Cataract

United States
Research Insight LLC

Completed

Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization (CLEAN)

Dry Eye

United States
Research Insight LLC

Completed

Evaluation of the Accuracy & Safety of the LaserArcs Nomogram

Cataract | Astigmatism

United States
Cancer Insight, LLC

Completed

Immunotherapy Vaccine and Herceptin in Breast Cancer

Breastcancer
Research Insight LLC

Completed

The DEPOT Study (Dry Eye Prescription Options for Therapy)

Dry Eye

United States
Research Insight LLC

Completed

Vivity Insight: A Study of Patient Satisfaction and Visual Performance

Cataract

United States
Research Insight LLC

Completed

Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery

Dry Eye Syndromes

United States
Research Insight LLC

Completed

A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%

Cataract

United States
Research Insight LLC

Completed

Comparison of Pre-operative Measurements With Intraoperative Aberrometry in Predicting Correction for Low Toric Lens Correction in Cataract Surgery

Cataract Surgery

United States
BioSig Technologies, Inc.

Completed

Novel Cardiac Signal Processing System

Cardiac Arrhythmia

United States
Molecular Insight Pharmaceuticals, Inc.

Approved for marketing

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome (Zeus-ACS)

Acute Coronary Syndrome

United States, Canada
Molecular Insight Pharmaceuticals, Inc.

Withdrawn

Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors

Malignant Carcinoid Tumor
Molecular Insight Pharmaceuticals, Inc.

Completed

Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Terminated

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Metastatic Melanoma

United States
Limbic Limited
Insight Healthcare

Recruiting

Evaluate Treatment Outcomes For AI-Enabled Information Collection Tool For Clinical Assessments In Mental Healthcare

Mental Health Issue

United Kingdom
Molecular Insight Pharmaceuticals, Inc.

Unknown

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Pheochromocytoma | Paraganglioma | Carcinoid
BioSig Technologies, Inc.

Completed

Redo AF Sub Study (of the Pure EP 2.0 Main Study)

Atrial Fibrillation Recurrent

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer (proSPECT-AS)

Prostate Cancer

United States, Canada
Molecular Insight Pharmaceuticals, Inc.

Completed

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Neuroblastoma

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Prostate Cancer

United States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
Molecular Insight Pharmaceuticals, Inc.

Completed

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Molecular Insight Pharmaceuticals, Inc.

Withdrawn

Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma

Neuroblastoma

United States, Canada
Molecular Insight Pharmaceuticals, Inc.

Completed

A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Terminated

Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

Prostate Cancer

United States
Insight Therapeutics, LLC
Brown University

Completed

High Dose Influenza Vaccine in Nursing Home - Pilot Study

Influenza

United States
Sheffield Hallam University
Symprove UK; Biomesight

Recruiting

Investigation of the Use of a Probiotic Supplement in People With Long COVID

Long COVID

United Kingdom
ProSight
Tel-Aviv Sourasky Medical Center

Completed

Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy

Prostate Cancer

Israel
BriaCell Therapeutics Corporation
Cancer Insight, LLC

Completed

SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer

Breast Neoplasm | Breastcancer

United States
InSight Vision Center Medical Group, Inc

Recruiting

Hydrus Microstent as a Quality of Life Consideration

Open Angle Glaucoma

United States
Insight Therapeutics, LLC
Brown University; Seqirus

Completed

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

Influenza | Influenza, Human | Influenza-like Illness

United States
British Columbia Cancer Agency
Insight Genetics

Completed

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients (PCRTALK)

Nonsmall Cell Lung Cancer

Canada
Cancer Insight, LLC
Elios Therapeutics, LLC

Completed

Phase IIB TL + YCWP + DC in Melanoma

Melanoma

United States

3

Subscribe